Treatment of patients with breast cancer or prostate cancer: A panel discussion (part 2)

Charles A. Coltman; Jeffrey S. Abrams; Joseph Aisner; Julia M. Cruz; Marc Hellerstein; Alexander Paterson; Lee Schacter; Richard V. Smalley; Jamie H. Von Roenn; Peter Venner

doi:10.5555/uri:pii:009377549090013s

Related publications

Article2005

Session 26: Evening Panel Discussion Nanoelectronics - Now or Never?

M. Lundström, Joerg Appenzeller, Jason E. Heath, Mary Grace Reed, R. Chau, Mark Horowitz, J. M. TOUR, André DeHon, Charles M. Lieber, V.V. Zhirnov, J.D. Meindl

Article2021

Treatment with abiraterone or enzalutamide does not impair immunological response to COVID-19 vaccination in prostate cancer patients

Michalis Liontos, Evangelos Terpos, Elena Kunadis, Flora Zagouri, Αlexandros Briasoulis, Efi Skafida, Oraianthi Fiste, Christos Markellos, Αngeliki Andrikopoulou, Sentiljana Gumeni, Maria Kaparelou, Konstantinos Koutsoukos, Maria Gavriatopoulou, Efstathios Kastritis, Ioannis P. Trougakos, Meletios A Dimopoulos

Chapter in a book2001

Denial of Service — Panel Discussion

Virgil D. Gligor, Matt Blaze, John P A Ioannidis

Article2022

Resveratrol in Cancer Treatment with a Focus on Breast Cancer

Hamid Reza Gilasi, Michael R Hamblin, Hamed Mirzaei, Hamed Kowsari, Amirhossein Davoodvandi, Fatemeh Dashti, Seyed Mohamad Ali Mirazimi, Zahra Razaghi Bahabadi, Michael Aschner, Amirhossein Sahebkar

Article2008

Osteonecrosis of the jaw (ONJ) in patients with prostate (PC) or breast (BC) cancer treated with bisphosphonates: Study of the effect of the application of preventive measures

A. Bamias, Efstathios Kastritis, Ioannis Melakopoulos, Dimitra Gika, Μαρία Ρούσσου, Magdalini Migkou, Evangelos Eleftherakis-Papaiakovou, Meletios A Dimopoulos